FACET BIOTECH CORP (FACT)

Healthcare: Biotechnology

Brokerage Ratings
Closing price on 12/31/2009: $17.55
Filers holding this stock on 12/31/2009: 93
Aggregate shares on 12/31/2009: 19,759,100
Aggregate shares on 09/30/2009: 18,392,729
Percent change: 7.428865%
View insider trading info since Jan. 1 2008
Quarter 1: Quarter 2:
Brokerage Ratings on this stock:
Positive:
0
Neutral:
2
Negative:
0
Brokerage Date Issued Rating Price Target
BMO CAPITAL MARKETS 03/14/2010 MARKET PERFORM
MERRIMAN 03/10/2010 NEUTRAL
Schedule 13d filings involving this stock
Filing Company Subject Company Date of Filing
View Schedule 13D BAUPOST GROUP LLC/MA FACET BIOTECH CORP 04/08/2009
View Amended Schedule 13D BAUPOST GROUP LLC/MA FACET BIOTECH CORP 04/27/2009
View Amended Schedule 13D BAUPOST GROUP LLC/MA FACET BIOTECH CORP 09/09/2009
View Schedule 13D BIOTECHNOLOGY VALUE FUND L P FACET BIOTECH CORP 09/29/2009
View Amended Schedule 13D BIOTECHNOLOGY VALUE FUND L P FACET BIOTECH CORP 12/15/2009
View Amended Schedule 13D BAUPOST GROUP LLC/MA FACET BIOTECH CORP 12/16/2009
View Amended Schedule 13D BIOTECHNOLOGY VALUE FUND L P FACET BIOTECH CORP 02/02/2010
View Amended Schedule 13D BAUPOST GROUP LLC/MA FACET BIOTECH CORP 03/17/2010
Non-derivative Insider Transactions
Transaction Date Owner Shares Purchased/Sold Edgar filing
09/04/2009
BAUPOST GROUP LLC/MA
SAK CORP
KLARMAN SETH A
 0 View Filing
01/27/2010
BVF PARTNERS L P/IL
BIOTECHNOLOGY VALUE FUND L P
BIOTECHNOLOGY VALUE FUND II LP
BVF INVESTMENTS LLC
LAMPERT MARK N
BVF INC/IL
 271,600 View Filing
02/02/2010
BVF PARTNERS L P/IL
BIOTECHNOLOGY VALUE FUND L P
BIOTECHNOLOGY VALUE FUND II LP
BVF INVESTMENTS LLC
LAMPERT MARK N
BVF INC/IL
 156,749 View Filing
02/05/2010
BVF PARTNERS L P/IL
BIOTECHNOLOGY VALUE FUND L P
BIOTECHNOLOGY VALUE FUND II LP
BVF INVESTMENTS LLC
LAMPERT MARK N
BVF INC/IL
 39,200 View Filing
03/16/2010
BAUPOST GROUP LLC/MA
SAK CORP
KLARMAN SETH A
 0 View Filing